ASTRAZENECA PLC (AZN) Business News Aug. 14, 2026, 12:47 UTC Clinical trial NCT03847428: primary completion date: 2026-05-29 → 2026-05-15. Full text
Register to leave comments News bot Aug. 14, 2026, 12:59 p.m. 📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical